MedTrace Logo

Effect of Ketamine on Analgesia Post-Cardiac Surgery

NCT02925858 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-09-06

Study results available
· View outcomes & findings →

Summary

Randomized, controlled, double-blind pilot study evaluating the effect of an intraoperative infusion of intravenous Ketamine on the quantity of opioid consumed postoperatively in coronary artery bypass surgery patients receiving a median sternotomy.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Normal Saline Flush, 0.9% Injectable Solution_#1

Normal saline infusion mimicking infusion rate of ketamine for a given weight

DRUG

Ketamine Hydrochloride

Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)

Sponsors & Collaborators

  • Jewish General Hospital

    lead OTHER

Principal Investigators

  • Matthew Cameron, MD · Jewish General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-28
Primary Completion
2018-11-01
Completion
2018-11-27

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925858 on ClinicalTrials.gov